...
机译:人胰高血糖素样肽-1类似物利拉鲁肽在糖尿病小鼠模型中通过调节细胞动力学以及抑制氧化性和内质网应激来保存胰腺β细胞。
Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan;
Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan;
Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan;
Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan;
Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan;
Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, K;
Apoptosis; Beta cell mass; Cellular differentiation; Cellular proliferation; ER stress; Glucagon-like peptide-1; Oxidative stress;
机译:人胰高血糖素样肽-1类似物利拉鲁肽在糖尿病小鼠模型中通过调节细胞动力学以及抑制氧化性和内质网应激来保存胰腺β细胞。
机译:人胰高血糖素样肽-1类似物利拉鲁肽在糖尿病小鼠模型中通过调节细胞动力学以及抑制氧化性和内质网应激来保存胰腺β细胞。
机译:维格列汀可通过糖尿病小鼠模型中氧化和内质网应激的发育调节和抑制作用来保护胰腺β细胞的质量和功能
机译:胰腺β细胞中粗糙内质网亚颗粒的分子表征
机译:胰高血糖素样肽-1(GLP-1)和Liraglutide,一种合成GLP-1模拟,通过钙和AMPK依赖机制抑制人主动脉内皮细胞中的炎症
机译:人胰高血糖素样肽-1类似物利拉鲁肽在糖尿病小鼠模型中通过调节细胞动力学以及抑制氧化性和内质网应激来保存胰腺β细胞。
机译:人胰高血糖素样肽-1类似物利拉鲁肽在糖尿病小鼠模型中通过调节细胞动力学以及抑制氧化性和内质网应激来保存胰腺β细胞。